Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial-Reference-Cited by-同舟云学术

Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial

Published:2012-06-13 Issue:9 Volume:27 Page:3540-3546
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Almquist T.,Jacobson S. H.,Lins P.-E.,Farndale R. W.,Hjemdahl P.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/27/9/3540/7639708/gfs183.pdf

Reference42 articles.

1. Executive Summary: Standards of Medical Care in Diabetes—2010

2. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

3. Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999

4. Inflammation in Atherosclerosis

5. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

2. Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study;Kidney360;2022-12

3. The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials;Inflammopharmacology;2022-08-21

4. Platelet-Neutrophil Interactions and Thrombo-inflammatory Complications in Type 2 Diabetes Mellitus;Current Pathobiology Reports;2022-03

5. The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia;Expert Opinion on Drug Safety;2016-03-16